Syra Health Corp.
SYRA
$0.3401
-$0.0189-5.27%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -4.25M | -4.19M | -3.60M | -2.94M | -2.56M |
Total Depreciation and Amortization | 164.70K | 86.90K | 50.00K | 139.00K | 136.70K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | 4.00K |
Total Other Non-Cash Items | -1.40K | 57.80K | 65.80K | -57.30K | 44.60K |
Change in Net Operating Assets | -387.40K | -388.00K | -31.00K | 97.70K | 147.10K |
Cash from Operations | -4.47M | -4.43M | -3.51M | -2.76M | -2.22M |
Capital Expenditure | -11.10K | -11.10K | -11.20K | -15.30K | -60.20K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -11.10K | -11.10K | -11.20K | -15.30K | -60.20K |
Total Debt Issued | 0.00 | 1.30M | 1.50M | 3.05M | 4.55M |
Total Debt Repaid | -1.23M | -1.80M | -1.67M | -2.33M | -2.18M |
Issuance of Common Stock | 7.80M | 6.18M | 6.18M | 5.33M | 0.00 |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 589.10K | 323.50K | 155.30K | 0.00 | -738.50K |
Cash from Financing | 7.16M | 6.00M | 6.17M | 6.05M | 1.63M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 2.68M | 1.56M | 2.64M | 3.28M | -650.50K |